Download PDF
Thromb Haemost 1966; 15(01/02): 273-283
DOI: 10.1055/s-0038-1649427
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Rapid Determination of Antifibrinolysin (Antiplasmin) in Plasma[*]

L. B Nanninga
1   Department of Physiology University of Texas Medical Branch Galveston, Texas
,
M. M Guest
1   Department of Physiology University of Texas Medical Branch Galveston, Texas
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

A nephelometric assay of antifibrinolysin in plasma is described. This assay is based on the inhibition of fibrinogenolysis. An equation is derived to calculate the antifibrinolysin content. Only the activity of the rapid acting antifibrinolysin is obtained. The values for antifibrinolysin are given in mol/L based on a molecular weight 57.000 (1). All values are based (standardized) on the inhibition of fibrinolysin by crystalline soybean trypsin inhibitor.

* Supported by Grants 5ROT-06238-04 and HE 03717-07 from the USPHS.


 

  • References

  • 1 Nanninga L. B, Guest M. M. On the interaction of fibrinolysin (plasmin) with the inhibitors antifibrinolysin and soybean trypsin inhibitor. Arch. Biochem. Biophys 108: 542 1964;
    CrossrefPubMedGoogle Scholar
  • 2 Ware A. G, Guest M. M, Seegers W. H. Fibrinogen: with special reference to its preparation and certain properties of the product. Arch. Biochem. Biophys 13: 231 1947;
    PubMedGoogle Scholar
  • 3 Guest M. M, Daly B. M, Ware A. G, Seegers W. H. A Study of antifibrinolysin activity in the plasma of various animal species. J. clin. Invest 27: 785 1948;
    CrossrefPubMedGoogle Scholar
  • 4 Nanninga L. B, Guest M. M. Blocking of inhibition of fibrinolysin by mercurials and oxidizing agents. Arch. Biochem. Biophys 109: 607 1965;
    CrossrefPubMedGoogle Scholar
  • 5 Blix S. The stability of fibrinolytic inhibitors in human serum and the inhibitor content in animal sera. Scand. J. clin. Lab. Invest 16: 614 1964;
    CrossrefPubMedGoogle Scholar
  • 6 de Wit Dudok C. Investigation on the inhibitors of the fibrinolytic system. Thrombos. Diathes. haemorrh. (Stuttg) 12: 105 1964;
    PubMedGoogle Scholar
  • 7 Nanninga L. B. Fibrinogen: preparation, photoelectric determination, molecular weight, viscosity, formol titration before and after clotting. Arch, néerl. Physiol 28: 241 1946;
    PubMedGoogle Scholar
  • 8 Parfentjew I. A, Johnson M. L, Clijfton E. E. The determination of plasma fibrinogen by turbidity with ammonium sulphate. Arch. Biochem. Biophys 46: 470 1953;
    CrossrefPubMedGoogle Scholar
  • 9 Mihalyi E, Godfrey J. E. Digestion of fibrinogen by trypsin. Biochim. biophys. Acta (Amst) 67: 73-90 1963;
    CrossrefPubMedGoogle Scholar
  • 10 Seegers W. H, Nieft M, Vandenbelt J. M. Decomposition products of fibrinogen and fibrin. Arch. Biochem 07: 15 1945;
    PubMedGoogle Scholar
  • 11 Niewiarowski S, Kowalski E. Un nouvel anticoagulant dérivé du fibrinogène. Rev. Hémat 13: 320 1958;
    PubMedGoogle Scholar
  • 12 Triantaphyllopoulos E, Triantaphyllopoulos D. C. Variability of the anticoagulant fraction of incubated fibrinogen. Amer. J. Physiol 208: 521 1965;
    PubMedGoogle Scholar
  • 13 Maki M. Anticoagulant activity of digest products of fibrinogen by plasmin Tohoku. J. exp. Med 84: 201 1964;
    PubMedGoogle Scholar
  • 14 Ratnoff O. D. Fibrinogen and fibrin as substrates for the proteolytic enzyme of plasma. J. clin. Invest 32: 473 1953;
    CrossrefPubMedGoogle Scholar
  • 15 Christensen L. R. Streptococcal fibrinolysis: a proteolytic reaction due to a serum enzyme activated by streptococcal fibrinolysin. J. gen. Physiol 28: 363 1944/45
    PubMedGoogle Scholar
  • 16 Gajewski J, Alexander B. Effect of plasmin on fibrinogen and fibrin. Amer. J. Physiol 206: 79 1964;
    PubMedGoogle Scholar
  • 17 Martin G. J. Inhibition of trypsin, chymotrypsin and plasmin by an inhibitor isolated from sheep serum. J. biol. Chem 237: 2099 1962;
    PubMedGoogle Scholar
  • 18 Derechin M. The assay of human plasminogen with casein as substrate. Biochem. J 78: 443 1961;
    CrossrefPubMedGoogle Scholar
  • 19 Kunitz M. Crystalline soybean trypsin inhibitor. J. gen. Physiol 30: 291-311 1947;
    CrossrefPubMedGoogle Scholar
  • 20 Ronwin E. The active center of plasmin. Biochim. biophys. Acta (Arnst) 38: 258 1960;
    CrossrefPubMedGoogle Scholar
  • 21 Jansen E. F, Balls A. K. The inhibition of α and β chymotrypsin and trypsin by diisopro- pylfluorophosphate. J. biol. Chem 194: 721 1952;
    PubMedGoogle Scholar
  • 22 Wu Y. V, Scheraga H. A. Studies of soybean trypsin inhibitor. I Physicochemical properties. Biochemistry 01: 698 1962;
    CrossrefPubMedGoogle Scholar
  • 23 Steiner R. F. The combination of trypsin with soybean inhibitor. Arch. Biochem. Biophys 49: 71 1954;
    CrossrefPubMedGoogle Scholar
  • 24 McLaren A. D. Some observations on a trypsin - trypsin inhibitor system. C.R. Lab. Carlsberg 28: 175 1952;
    PubMedGoogle Scholar
  • 25 Alkjaersig N. A, Fletcher P, Sherry S. The mechanism of clot dissolution by plasmin. J. clin. Invest 38: 1086 1959;
    CrossrefPubMedGoogle Scholar
  • 26 Norman P. S. Studies of the plasmin system. II Inhibition of plasmin by serum or plasma. J. exp. Med 108: 53 1958;
    CrossrefPubMedGoogle Scholar
  • 27 Ablondi F. B, Hagan J. J, Philips M, De Renzo E. G. Inhibition of plasmin, trypsin and the streptokinase activated fibrinolytic system by ε aminocaproic acid. Arch. Biochem. Biophys 82: 153 1959;
    CrossrefPubMedGoogle Scholar
  • 28 McNicol G. P, Fletcher A. P, Alkjaersig N, Sherry S. The absorption distribution and excretion of e aminocaproic acid following oral and intravenous administration to man. J. Lab. clin. Med 59: 15 1962;
    PubMedGoogle Scholar
  • 29 Sherry S, Fletcher A. P, Alkjaersig N, Sawyer W. D. ε aminocaproic acid: “a potent antifibrinolytic agent”. Trans. Ass. Amer. Phycns 72: 62 1959;
    PubMedGoogle Scholar
  • 30 Alkjaersig N, Fletcher A. P, Sherry S. α aminocaproic acid: an inhibitor of plasminogen activation. J. biol Chem 234: 832 1959;
    PubMedGoogle Scholar
  • 31 Bickford A. F, Taylor F. B, Sheena R. Inhibition of fibrinogen-plasmin reaction by co aminocarboxylic acids and alkylamines. Biochim. biophys. Acta (Amst) 92: 328 1964;
    PubMedGoogle Scholar
  • 32 Robbins K. C, Summaria L, Elwyn D, Barlow G. H. Further studies on the purification and characterization of human plasminogen and plasmin. J. biol. Chem 240: 541 1965;
    PubMedGoogle Scholar
  • 33 Nussenzweig V, Seligmann M. Analyse par des methodes immunochimiques de la degradation par la plasmine du fibrinogène humain et de la fibrine a different stades. Rev. Hémat 15: 451 1960;
    PubMedGoogle Scholar